Loperamide associated torsades de pointes, in the setting of complete heart block at marginally supratherapeutic dosing (20mg/day).
Robert GoodnoughMariko NomuraAdina BadeaKara L LynchNeal L BenowitzBen TsutaokaPublished in: Clinical toxicology (Philadelphia, Pa.) (2019)